Source: DD News
Context: Exercise is a cornerstone in managing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study led by an Indian-origin researcher.
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic Fatty Liver Disease (NAFLD), is a chronic liver condition linked to fat accumulation in the liver.
About Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD):
- What it is: MASLD is a liver disease caused by excessive fat build-up in the liver, often linked to metabolic dysfunction. It can progress to inflammation (MASH) and severe complications like liver fibrosis or cirrhosis.
- Causes:
- Obesity (BMI ≥ 30).
- Insulin resistance leading to poor blood sugar management.
- Type 2 diabetes.
- Dyslipidemia (high cholesterol and lipids).
- Symptoms:
- Fatigue and weakness.
- Right upper abdominal ache.
- Swollen belly and yellowing skin (in advanced cases).
- Severe cases may lead to cirrhosis or liver cancer.
- Diseases Associated:
- MASH (inflammation with scarring).
- Hepatocellular carcinoma (liver cancer).
- Increased risks of cardiovascular diseases, breast cancer, and colon cancer.
- Type 2 diabetes in non-diabetic individuals.
- Treatment:
- Lifestyle Changes: Weight loss and regular exercise to reduce liver fat and improve insulin sensitivity.
- Dietary Adjustments: Avoiding high-fat, high-sugar foods.
- Pharmacotherapy: For managing metabolic risk factors like diabetes and cholesterol.
- Exercise Protocols: Tailored regimens can benefit all patients, including those with advanced liver disease like cirrhosis.
Insta links:
